2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Interim Results of an Ongoing Open-label Safety Study of ADS-5102 (amantadine hydrochloride) Extended-Release Capsules for Treatment of Levodopa-Induced Dyskinesia (LID) (EASE LID 2 Study)

R. Hauser, R. Pahwa, C. Tanner, W. Oertel, S. Isaacson, M.J. Stempien, L. Felt, R. Johnson (Tampa, FL, USA)
Interleaved Stimulation for Freezing of Gait in Advanced Parkinson’s Disease: A Pilot Study

R. Rajan, S. Zafer, S. Krishnan, K. Kesavapisharady, A. Kishore (Trivandrum, India, India)
Intermuscular and cortico-muscular coherence of patients with writer’s cramp

H. Kumar, S. Choudhury, P. Chatterjee, R. Singh, S. Trivedi, S. Shubham, M. Baker, S. Baker (Kolkata, India)
Internet-based Cognitive Behavioral Therapy for general function in patients with Parkinson’s Disease: A randomized controlled trial.

M. Kraepelien, R. Schibbye, P. Svenningsson, N. Lindefors, V. Kaldo (Stockholm, Sweden)
Interrelation between chronic pain syndrome and cognitive and affective disturbances in patients with Parkinson’s disease

K. Stepanchenko (Kharkiv, Ukraine)
Interval from onset of Parkinson disease to onset of motor and non-motor complications in Leucine-rich repeat kinase 2 (LRRK2) G2019S positive versus matched PD controls

S. Gunzler, D. Riley, A. Wilson-Delfosse, S. Chen, J. Mieyal, C. Tatsuoka (Cleveland, OH, USA)
Intracerebroventricular administration of dopamine: A new therapeutic concept for Parkinson’s disease?

C. LALOUX, F. GOUEL, C. LACHAUD, K. Timmerman, A. Jonneaux, C. Moreau, R. BORDET, J.-c. DEVEDJIAN, D. DEVOS (LILLE, France)
Intracortical plasticity is preserved in de novo Parkinson’s disease: a tSMS study.

M. Dileone, V. Catanzaro, J. Obeso, G. Foffani (Mostoles, Spain)
Intracranial calcifications and dystonia associated with a novel deletion encompassing SLC20A2 and THAP1

L. Tochen, H. Singer, K. Baranano (Washington, DC, USA)
Intrajejunal levodopa infusion (ILI) for Parkinson’s Disease (PD): A Canadian Experience

P. Podgorny, P. McCann, K. Toore, G. Tremain, A. Lazarescu, O. Suchowersky (Edmonton, AB, Canada)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z